ATE480643T1 - Homogener nachweis von analyten - Google Patents

Homogener nachweis von analyten

Info

Publication number
ATE480643T1
ATE480643T1 AT05858303T AT05858303T ATE480643T1 AT E480643 T1 ATE480643 T1 AT E480643T1 AT 05858303 T AT05858303 T AT 05858303T AT 05858303 T AT05858303 T AT 05858303T AT E480643 T1 ATE480643 T1 AT E480643T1
Authority
AT
Austria
Prior art keywords
analytes
detection
methods
sensitive
homogeneous detection
Prior art date
Application number
AT05858303T
Other languages
English (en)
Inventor
Thomas Adams
Edward Jablonski
Original Assignee
Iris Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37570907&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE480643(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Iris Molecular Diagnostics Inc filed Critical Iris Molecular Diagnostics Inc
Application granted granted Critical
Publication of ATE480643T1 publication Critical patent/ATE480643T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6832—Enhancement of hybridisation reaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2304/00—Chemical means of detecting microorganisms
    • C12Q2304/10—DNA staining
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00—Reactions demanding special reaction conditions
    • C12Q2527/101—Temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/101—Homogeneous assay format, e.g. one pot reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/131—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a member of a cognate binding pair, i.e. extends to antibodies, haptens, avidin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/179—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being a nucleic acid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/10—Oligonucleotides as tagging agents for labelling antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials By The Use Of Fluid Adsorption Or Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT05858303T 2004-11-03 2005-11-03 Homogener nachweis von analyten ATE480643T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62495004P 2004-11-03 2004-11-03
PCT/US2005/040133 WO2006137932A2 (en) 2004-11-03 2005-11-03 Homogeneous analyte detection

Publications (1)

Publication Number Publication Date
ATE480643T1 true ATE480643T1 (de) 2010-09-15

Family

ID=37570907

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05858303T ATE480643T1 (de) 2004-11-03 2005-11-03 Homogener nachweis von analyten

Country Status (13)

Country Link
US (2) US8338579B2 (de)
EP (1) EP1842226B2 (de)
JP (2) JP5188808B2 (de)
KR (1) KR20070105967A (de)
CN (2) CN101137758B (de)
AT (1) ATE480643T1 (de)
AU (1) AU2005333156B2 (de)
CA (1) CA2585781A1 (de)
DE (1) DE602005023529D1 (de)
DK (1) DK1842226T3 (de)
ES (1) ES2352041T5 (de)
PT (1) PT1842226E (de)
WO (1) WO2006137932A2 (de)

Families Citing this family (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004042030A2 (en) * 2002-11-01 2004-05-21 Leucadia Technologies, Inc. Displacement sandwich immuno-pcr
JP5037350B2 (ja) * 2004-11-03 2012-09-26 アイリス モレキュラー ダイアグノスティクス， インコーポレイテッド 親和性分離のための微粒気泡
AU2005333156B2 (en) 2004-11-03 2011-05-26 Iris Molecular Diagnostics, Inc. Homogeneous analyte detection
US10416162B2 (en) 2007-12-20 2019-09-17 Monogram Biosciences, Inc. Her2 diagnostic methods
PL2252893T3 (pl) * 2008-02-21 2014-03-31 Iris Int Inc Sposób wczesnego określenia nawrotu po leczeniu nowotworu gruczołu krokowego
WO2010011901A1 (en) * 2008-07-24 2010-01-28 Innovative Biosensors, Inc. Detection of rna-dna duplex molecules
CA2764386C (en) * 2008-12-01 2018-05-01 Laboratory Corporation Of America Holdings P95-her2 antibodies and uses thereof
EP2387711B1 (de) 2009-01-15 2015-04-22 Laboratory Corporation of America Holdings Verfahren zur bestimmung von patientenreaktionen durch her-3-messung
CN102439452B (zh) * 2009-01-15 2015-04-15 美国控股实验室公司 通过测量her-2表达确定患者应答的方法
KR101029343B1 (ko) * 2009-07-30 2011-04-13 한국과학기술연구원 면역분석 기반의 항원 검출용 키트 및 항원 검출 방법
AU2010296018B2 (en) 2009-09-16 2016-05-05 Genentech, Inc. Coiled coil and/or tether containing protein complexes and uses thereof
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
AR080793A1 (es) 2010-03-26 2012-05-09 Roche Glycart Ag Anticuerpos biespecificos
JP2012003925A (ja) 2010-06-16 2012-01-05 Sony Corp 表示装置
WO2012085064A1 (en) 2010-12-23 2012-06-28 Roche Diagnostics Gmbh Detection of a posttranslationally modified polypeptide by a bi-valent binding agent
SG191153A1 (en) * 2010-12-23 2013-07-31 Hoffmann La Roche Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
WO2012085069A2 (en) * 2010-12-23 2012-06-28 Roche Diagnostics Gmbh Detection of a polypeptide dimer by a bivalent binding agent
CN103384681B (zh) * 2010-12-23 2018-05-18 霍夫曼-拉罗奇有限公司 结合剂
GB201101621D0 (en) * 2011-01-31 2011-03-16 Olink Ab Method and product
DE102011082353B4 (de) 2011-09-08 2021-04-01 Siemens Aktiengesellschaft Stator für einen Elektromotor
GB201201547D0 (en) 2012-01-30 2012-03-14 Olink Ab Method and product
EP2810296A4 (de) 2012-02-03 2015-12-30 Rapiscan Systems Inc Kombiniertes streu- und übertragungssystem mit mehrfachansicht
RU2644341C2 (ru) 2012-02-10 2018-02-08 Дженентек, Инк. Одноцепочечные антитела и другие гетеромультимеры
US10670740B2 (en) 2012-02-14 2020-06-02 American Science And Engineering, Inc. Spectral discrimination using wavelength-shifting fiber-coupled scintillation detectors
EP3321378B1 (de) 2012-02-27 2021-11-10 Becton, Dickinson and Company Zusammensetzungen für molekularen zählung
JP6203838B2 (ja) 2012-06-27 2017-09-27 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 少なくとも２つの異なる結合実体を含む、テーラーメイドの高度に選択的かつ多重特異的なターゲティング実体を選択および作製するための方法、ならびにその使用
CN104395340B9 (zh) 2012-06-27 2018-11-30 弗·哈夫曼-拉罗切有限公司 包含至少两个不同靶向实体的定制选择性和多特异性治疗分子的方法及其用途
EP2867254B1 (de) 2012-06-27 2017-10-25 F. Hoffmann-La Roche AG Verfahren zum herstellen von antikörper-fc-region-konjugaten mit mindestens einer bindungsstelle, die spezifisch an ein target bindet, und verwendungen davon
US10081842B2 (en) 2012-08-07 2018-09-25 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Prostate cancer gene expression profiles
JP6405311B2 (ja) 2012-09-14 2018-10-17 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 少なくとも２つの異なる実体を含む分子を作製および選択するための方法ならびにその使用
JP2016514455A (ja) 2013-03-15 2016-05-23 フリューダイム・コーポレイション 単一細胞における標的タンパク質および標的核酸の同時検出
TWI553122B (zh) * 2013-05-21 2016-10-11 Ｓｒｃ公司 用於分子與蛋白質基於螢光之定量偵測的方法與系統
ES2711168T3 (es) 2013-08-28 2019-04-30 Becton Dickinson Co Análisis masivo en paralelo de células individuales
SG10201908167YA (en) * 2013-09-04 2019-10-30 Fluidigm Corp Proximity assays for detecting nucleic acids and proteins in a single cell
WO2015103287A2 (en) 2013-12-30 2015-07-09 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Genomic rearrangements associated with prostate cancer and methods of using the same
CN103728452B (zh) * 2014-01-23 2015-06-24 湖南大学 一种检测黄曲霉素b1的胶体金免疫试剂盒及其制备方法
CN103728451B (zh) * 2014-01-23 2015-06-24 湖南大学 一种检测赭曲霉素a的胶体金免疫试剂盒及其制备方法
US9909167B2 (en) 2014-06-23 2018-03-06 The Board Of Trustees Of The Leland Stanford Junior University On-slide staining by primer extension
NL2013857B1 (en) * 2014-11-21 2016-10-11 Piculet Biosciences Tech B V Self-assembled bivalent ligand complex (SABLC) libraries and methods for screening such libraries.
JP6721590B2 (ja) 2014-12-03 2020-07-15 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 多重特異性抗体
US11291931B2 (en) 2014-12-15 2022-04-05 Akadeum Life Sciences, Inc. Method and system for buoyant separation
ES2836802T3 (es) 2015-02-27 2021-06-28 Becton Dickinson Co Códigos de barras moleculares espacialmente direccionables
JP6746603B2 (ja) 2015-03-20 2020-08-26 ラピスカン システムズ、インコーポレイテッド 手持ち式携帯型後方散乱検査システム
ES2934982T3 (es) 2015-03-30 2023-02-28 Becton Dickinson Co Métodos para la codificación con códigos de barras combinatorios
EP3283638B1 (de) * 2015-04-17 2022-06-08 The Regents of The University of California Verfahren zum nachweis von agglutination und verwendung von kits bei der durchführung davon
WO2016172373A1 (en) 2015-04-23 2016-10-27 Cellular Research, Inc. Methods and compositions for whole transcriptome amplification
CN113376364B (zh) 2015-08-10 2025-02-25 上海宜晟生物科技有限公司 步骤简化、小样品、快速、易使用的生物/化学分析装置和方法
EP3347465B1 (de) 2015-09-11 2019-06-26 Cellular Research, Inc. Verfahren und zusammensetzung zur standardisierung von nukleinsäure bibliothek
SG10202104563UA (en) 2015-09-14 2021-06-29 Essenlix Corp Device and system for analyzing a sample, particularly blood, as well as methods of using the same
CN108633304B (zh) 2015-09-14 2020-08-14 艾森利克斯公司 采集分析蒸汽凝析，特别是呼出气凝析的装置与系统，以及使用方法
GB201518655D0 (en) 2015-10-21 2015-12-02 Olink Ab Method for generating proximity probes
US10301677B2 (en) 2016-05-25 2019-05-28 Cellular Research, Inc. Normalization of nucleic acid libraries
EP4628631A3 (de) 2016-05-27 2025-12-17 President and Fellows of Harvard College Bedingte primerextension zur einzelmolekülerkennung
US10202641B2 (en) 2016-05-31 2019-02-12 Cellular Research, Inc. Error correction in amplification of samples
US10640763B2 (en) 2016-05-31 2020-05-05 Cellular Research, Inc. Molecular indexing of internal sequences
CN106124781B (zh) * 2016-07-07 2018-01-02 中国农业科学院农业质量标准与检测技术研究所 一种基于适配体夹心荧光淬灭技术检测去甲基睾酮的方法
EP3490616B1 (de) 2016-07-27 2022-09-28 The Board of Trustees of the Leland Stanford Junior University Hochmultiplexierte fluoreszente bildgebung
EP3516400B1 (de) 2016-09-26 2023-08-16 Becton, Dickinson and Company Messung der proteinexpression mit reagenzien mit strichcodierten oligonukleotidsequenzen
DE102016221875B4 (de) * 2016-11-08 2018-06-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Stationäre Phase zur Detektion eines bestimmten Analyten in einem Gemisch, Verwendungen hiervon und Verfahren zur Detektion eines bestimmten Analyten in einem Gemisch
EP3554254B1 (de) 2016-12-15 2025-05-07 Société des Produits Nestlé S.A. Zusammensetzungen und verfahren zur modulierung von bakterien bei einer haustier
WO2018119318A1 (en) 2016-12-21 2018-06-28 Essenlix Corporation Devices and methods for authenticating a sample and use of the same
US11319583B2 (en) 2017-02-01 2022-05-03 Becton, Dickinson And Company Selective amplification using blocking oligonucleotides
US11274996B2 (en) 2017-02-07 2022-03-15 Essenlix Corporation Compressed open flow assay and use
CN119000153A (zh) 2017-02-08 2024-11-22 上海宜晟生物科技有限公司 样品分析装置及其使用
US12151246B2 (en) 2017-02-08 2024-11-26 Essenlix Corporation Molecular manipulation and assay with controlled temperature
CN111936837B (zh) 2017-02-08 2024-06-07 上海宜晟生物科技有限公司 Qmax测定及应用
WO2018148469A1 (en) 2017-02-08 2018-08-16 Essenlix Corp. Bio/chemical material extraction and assay
WO2018148609A2 (en) 2017-02-09 2018-08-16 Essenlix Corporation Colorimetric assays
SG11201906689SA (en) * 2017-02-09 2019-08-27 Atlas Antibodies Ab Method for determining levels of interactions between biomolecules
US11940382B2 (en) 2017-02-09 2024-03-26 Essenlix Corporation Assay with amplification
CA3053114A1 (en) 2017-02-09 2018-08-16 Essenlix Corporation Assay using different spacing heights
CA3053295A1 (en) 2017-02-15 2018-08-23 Essenlix Corporation Assay with rapid temperature change
CN120195095A (zh) 2017-02-16 2025-06-24 上海宜晟生物科技有限公司 采用纹理化表面的测定方法及装置
CA3059559A1 (en) 2017-06-05 2018-12-13 Becton, Dickinson And Company Sample indexing for single cells
WO2018231877A1 (en) 2017-06-12 2018-12-20 Essenlix Corporation Homogeneous assay
US11280706B2 (en) 2017-08-01 2022-03-22 Essenlix Corporation Dilution calibration
WO2019028123A1 (en) 2017-08-01 2019-02-07 Essenlix Corporation COLLECTION, MAINTENANCE AND DETERMINATION OF SAMPLES
CN112689758B (zh) 2017-08-01 2025-03-28 上海宜晟生物科技有限公司 检查药物对微生物影响的装置和方法
WO2019075244A1 (en) 2017-10-11 2019-04-18 Essenlix Corporation CONTAINING A LIQUID SAMPLE
US11393561B2 (en) 2017-10-13 2022-07-19 Essenlix Corporation Devices and methods for authenticating a medical test and use of the same
US10807095B2 (en) 2017-10-26 2020-10-20 Essenlix Corporation Making and tracking assay card
US11237113B2 (en) 2017-10-26 2022-02-01 Essenlix Corporation Rapid pH measurement
US11609224B2 (en) 2017-10-26 2023-03-21 Essenlix Corporation Devices and methods for white blood cell analyses
US11648551B2 (en) 2017-12-12 2023-05-16 Essenlix Corporation Sample manipulation and assay with rapid temperature change
US11510608B2 (en) 2017-12-14 2022-11-29 Essenlix Corporation Devices, systems, and methods for monitoring hair
US11156606B2 (en) 2018-01-11 2021-10-26 Essenlix Corporation Homogeneous assay (II)
US20210270851A1 (en) * 2018-02-22 2021-09-02 The Board Of Trustees Of The Leland Stanford Junior University Biomarker for diagnosing autism spectrum disorder
JP7358388B2 (ja) 2018-05-03 2023-10-10 ベクトン・ディキンソン・アンド・カンパニー 反対側の転写物末端における分子バーコーディング
ES2945191T3 (es) 2018-05-03 2023-06-29 Becton Dickinson Co Análisis de muestras multiómicas de alto rendimiento
EP3811117A4 (de) 2018-06-20 2022-03-16 American Science & Engineering, Inc. An wellenlängenversatzfolie gekoppelte szintillationsdetektoren
CN112437692B (zh) 2018-07-09 2022-06-24 爱卡德姆生命科学公司 用于有浮力颗粒处理的系统和方法
US11885952B2 (en) 2018-07-30 2024-01-30 Essenlix Corporation Optics, device, and system for assaying and imaging
US11639517B2 (en) 2018-10-01 2023-05-02 Becton, Dickinson And Company Determining 5′ transcript sequences
JP7618548B2 (ja) 2018-11-08 2025-01-21 ベクトン・ディキンソン・アンド・カンパニー ランダムプライミングを使用した単一細胞の全トランスクリプトーム解析
US11492660B2 (en) 2018-12-13 2022-11-08 Becton, Dickinson And Company Selective extension in single cell whole transcriptome analysis
EP4242322B1 (de) 2019-01-23 2024-08-21 Becton, Dickinson and Company Mit antikörpern assoziierte oligonukleotide
WO2020154620A2 (en) * 2019-01-25 2020-07-30 Psomagen Inc. Antibody-dna conjugates and hpv detection and treatment
WO2020167920A1 (en) 2019-02-14 2020-08-20 Cellular Research, Inc. Hybrid targeted and whole transcriptome amplification
US11965208B2 (en) 2019-04-19 2024-04-23 Becton, Dickinson And Company Methods of associating phenotypical data and single cell sequencing data
CN114051534B (zh) 2019-07-22 2025-02-21 贝克顿迪金森公司 单细胞染色质免疫沉淀测序测定
JP7522189B2 (ja) 2019-11-08 2024-07-24 ベクトン・ディキンソン・アンド・カンパニー 免疫レパートリーシーケンシングのための完全長ｖ（ｄ）ｊ情報を得るためのランダムプライミングの使用
US11649497B2 (en) 2020-01-13 2023-05-16 Becton, Dickinson And Company Methods and compositions for quantitation of proteins and RNA
CN115335520A (zh) 2020-01-29 2022-11-11 贝克顿迪金森公司 用于通过测序对单细胞进行空间映射的条形码化的孔
EP4111168A1 (de) 2020-02-25 2023-01-04 Becton Dickinson and Company Bispezifische sonden zur ermöglichung der verwendung von einzelzellenproben als einzelfarbkompensationssteuerung
GB202004472D0 (en) 2020-03-27 2020-05-13 Olink Proteomics Ab Method for detecting analytes of varying abundance
GB202004469D0 (en) 2020-03-27 2020-05-13 Olink Proteomics Ab Controls for proximity detection assays
AU2021241898A1 (en) 2020-03-27 2022-10-13 Olink Proteomics Ab Method for detecting analytes of varying abundance
CN115605614A (zh) 2020-05-14 2023-01-13 贝克顿迪金森公司（Us） 用于免疫组库谱分析的引物
US12157913B2 (en) 2020-06-02 2024-12-03 Becton, Dickinson And Company Oligonucleotides and beads for 5 prime gene expression assay
US11932901B2 (en) 2020-07-13 2024-03-19 Becton, Dickinson And Company Target enrichment using nucleic acid probes for scRNAseq
WO2022026909A1 (en) 2020-07-31 2022-02-03 Becton, Dickinson And Company Single cell assay for transposase-accessible chromatin
US12043673B2 (en) * 2020-10-15 2024-07-23 City Of Hope Complementary RNA linked bispecific T-cell engaging antibodies
GB202017873D0 (en) 2020-11-12 2020-12-30 Olso Unversitetssykehus Hf Method of determining DLBCL prognosis
CN116635533A (zh) 2020-11-20 2023-08-22 贝克顿迪金森公司 高表达的蛋白和低表达的蛋白的谱分析
US11340361B1 (en) 2020-11-23 2022-05-24 American Science And Engineering, Inc. Wireless transmission detector panel for an X-ray scanner
GB202018503D0 (en) 2020-11-25 2021-01-06 Olink Proteomics Ab Analyte detection method employing concatamers
CN116685850A (zh) 2020-12-15 2023-09-01 贝克顿迪金森公司 单细胞分泌组分析
CN112730840B (zh) * 2021-01-29 2023-10-17 章毅 鉴别cd44和cd24分子表型的方法
EP4392158A4 (de) 2021-08-26 2025-09-03 Akadeum Life Sciences Inc Verfahren und system zur schwimmenden trennung
EP4409607A1 (de) 2021-10-01 2024-08-07 Rapiscan Holdings, Inc. Verfahren und systeme zur gleichzeitigen erzeugung mehrerer weitgehend ähnlicher röntgenstrahlen
EP4428533A4 (de) * 2021-11-04 2025-01-22 Toppan Holdings Inc. Verfahren zum nachweis einer zielsubstanz
EP4504367A1 (de) 2022-04-01 2025-02-12 Akadeum Life Sciences, Inc. Verfahren und system für schwimmfähige partikelgestützte zelltherapie
CN120187865A (zh) 2022-11-11 2025-06-20 欧邻科蛋白质组学公司 邻近探针文库和使用方法
EP4382534A1 (de) 2022-12-06 2024-06-12 Biomérieux Synthetisches peptid zur verwendung in einem immunmolekulartest
US12099050B2 (en) 2023-02-14 2024-09-24 Akadeum Life Sciences, Inc. Method and system for partially or fully automated buoyancy-assisted separation
WO2025012226A1 (en) 2023-07-12 2025-01-16 Olink Proteomics Ab Method, components and software for detecting a systematic error in a protein detection system
WO2025031642A1 (en) 2023-08-07 2025-02-13 Olink Proteomics Ab A method for determining run errors for an analysis-method for quantifying a plurality of analytes in a plurality of biological samples
WO2025155806A1 (en) * 2024-01-19 2025-07-24 Luminex Corporation Light induced linking assay and uses thereof

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582956A (en) * 1976-07-30 1981-01-21 Ici Ltd Composite magnetic particles
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
DE3100535A1 (de) 1981-01-10 1982-08-12 Dr. Karl Thomae Gmbh, 7950 Biberach "neue carbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2571498B1 (fr) * 1984-10-04 1988-04-08 Immunotech Sa Procede de separation de cellules utilisant des anticorps et des billes de faible densite
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4618525A (en) * 1985-06-03 1986-10-21 Minnesota Mining And Manufacturing Company Coated glass microbubbles and article incorporating them
US4824776A (en) * 1985-07-25 1989-04-25 Molecular Biosystems, Inc. Method for increasing the sensitivity of nucleic acid hybridization assays
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4933447A (en) * 1987-09-24 1990-06-12 Ss Pharmaceutical Co., Ltd. Quinoline derivatives
US4957656A (en) 1988-09-14 1990-09-18 Molecular Biosystems, Inc. Continuous sonication method for preparing protein encapsulated microbubbles
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5766849A (en) * 1989-07-11 1998-06-16 Gen-Probe Incorporated Methods of amplifying nucleic acids using promoter-containing primer sequence
US5427930A (en) 1990-01-26 1995-06-27 Abbott Laboratories Amplification of target nucleic acids using gap filling ligase chain reaction
SE9002480D0 (sv) * 1990-07-23 1990-07-23 Hans Lilja Assay of free and complexed prostate-specific antigen
EP0488152A3 (en) 1990-11-30 1992-11-25 Hitachi, Ltd. Method for immunoassay and apparatus therefor
WO1992015708A1 (en) * 1991-02-27 1992-09-17 Amoco Corporation Methods for improving the sensitivity of hybridization assays
IE920778A1 (en) 1991-03-12 1992-09-23 Du Pont Method for specific binding assays using a releasable ligand
US5665539A (en) * 1991-07-12 1997-09-09 The Regents Of The University Of California Immuno-polymerase chain reaction system for antigen detection
US6723303B1 (en) * 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
CA2122030C (en) 1991-10-24 1997-03-04 Muthiah Manoharan Derivatized oligonucleotides having improved uptake and other properties
US5270184A (en) * 1991-11-19 1993-12-14 Becton, Dickinson And Company Nucleic acid target generation
US6172208B1 (en) * 1992-07-06 2001-01-09 Genzyme Corporation Oligonucleotides modified with conjugate groups
DE4232755A1 (de) 1992-09-26 1994-03-31 Schering Ag Mikropartikelpräparationen aus biologisch abbaubaren Mischpolymeren
JP3778925B2 (ja) * 1993-01-15 2006-05-24 ザ パブリック ヘルス リサーチ インスティチュート オブ ザ シティー オブ ニューヨーク インク 高感度核酸サンドイッチハイブリダイゼーション検定法及びキット
US5985548A (en) * 1993-02-04 1999-11-16 E. I. Du Pont De Nemours And Company Amplification of assay reporters by nucleic acid replication
ATE244406T1 (de) * 1993-05-10 2003-07-15 Nissui Pharm Co Ltd Verfahren zur bestimmung von mehr als einem immunologischen liganden und bestimmungsreagenz sowie satz dafuer
US5635602A (en) 1993-08-13 1997-06-03 The Regents Of The University Of California Design and synthesis of bispecific DNA-antibody conjugates
US5681697A (en) * 1993-12-08 1997-10-28 Chiron Corporation Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor
US5599677A (en) * 1993-12-29 1997-02-04 Abbott Laboratories Immunoassays for prostate specific antigen
US5648213A (en) * 1994-08-30 1997-07-15 Beckman Instruments, Inc. Compositions and methods for use in detection of analytes
JPH08178926A (ja) * 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
CN1046520C (zh) 1994-11-15 1999-11-17 法玛西雅厄普约翰美国公司 二环噁嗪及噻嗪噁唑烷酮抗菌剂
SE504798C2 (sv) * 1995-06-16 1997-04-28 Ulf Landegren Immunanalys och testkit med två reagens som kan tvärbindas om de adsorberats till analyten
DE19524133A1 (de) * 1995-07-03 1997-01-09 Bayer Ag Die Verwendung von neuen und bekannten kationischen 4,5-Dihydro-1H-1,2,3-triazoliumverbindungen als Farbstoffe, neue kationische 4,5-Dihydro-1H-1,2,3-triazoliumverbindungen und deren Herstellung
NO301198B1 (no) * 1995-07-14 1997-09-22 Alcatel Kabel Norge As Kabel, fremgangsmåte og impregneringsmasse
US5655539A (en) * 1996-02-26 1997-08-12 Abbott Laboratories Method for conducting an ultrasound procedure using an ultrasound transmissive pad
AT403803B (de) 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US6165942A (en) * 1996-10-03 2000-12-26 Nissan Chemical Industries, Ltd. Heterocycle-fused pyrimidinone derivative and herbicidal composition
US6083484A (en) * 1996-10-17 2000-07-04 Molecular Biosystems, Inc. Microparticles stabilized by polynuclear chromium complexes and their use as ultrasound contrast agents
US6245318B1 (en) * 1997-05-27 2001-06-12 Mallinckrodt Inc. Selectively binding ultrasound contrast agents
US6086540A (en) * 1997-10-07 2000-07-11 Molecular Biosystems, Inc. Methods of ultrasound imaging using echogenically persistent contrast agents
US6531278B1 (en) * 1998-01-14 2003-03-11 Utah State University Ligand-DNA composition for capture and detection of contaminants on a solid surface
IL139034A0 (en) * 1998-04-28 2001-11-25 Nycomed Imaging As Improvements in or relating to separation processes
US8063190B2 (en) * 1998-06-02 2011-11-22 Tom Robin Caine Boyde Nucleic acid-linked conjugates and methods for making and using them
US6214566B1 (en) * 1998-11-16 2001-04-10 The Administrators Of The Tulane Educational Fund Method for detecting anti-squalene antibodies
AU2410500A (en) 1999-01-11 2000-08-01 President And Fellows Of Harvard College Isothermal amplification of dna
WO2001027630A2 (en) * 1999-10-13 2001-04-19 The University Of British Columbia Methods to identify compounds that modulate neuronal activity
CA2391534A1 (en) * 1999-11-15 2001-05-25 Drug Innovation & Design, Inc. Selective cellular targeting: multifunctional delivery vehicles
US7306904B2 (en) * 2000-02-18 2007-12-11 Olink Ab Methods and kits for proximity probing
SE516272C2 (sv) † 2000-02-18 2001-12-10 Ulf Landegren Metoder och kit för analytdetektion mha proximitets-probning
US6511809B2 (en) * 2000-06-13 2003-01-28 E. I. Du Pont De Nemours And Company Method for the detection of an analyte by means of a nucleic acid reporter
US7439016B1 (en) 2000-06-15 2008-10-21 Digene Corporation Detection of nucleic acids by type-specific hybrid capture method
JP2004515219A (ja) 2000-06-15 2004-05-27 ボード・オブ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム 調節可能な触媒活性な核酸
US20020132260A1 (en) 2001-02-22 2002-09-19 Erlander Mark G. Quantitative immunohistochemistry (QIHC)
WO2002083951A1 (en) 2001-04-10 2002-10-24 Northeastern University Multiplexed ligand/protein binding assays with pna labels
EP1249500A1 (de) 2001-04-12 2002-10-16 chimera biotec GmbH Verfahren zum Nachweis einer Substanz
US6670386B2 (en) 2001-07-31 2003-12-30 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
CN1871517A (zh) 2002-02-19 2006-11-29 免疫公司 快速有效分离循环癌细胞的方法和试剂
KR100916889B1 (ko) * 2002-03-08 2009-09-09 아이드게노쉬쉐 테흐니쉐 호흐슐레 쥬리히 암호화된 자가-조립 화학적 라이브러리(ｅｓａｃｈｅｌ)
ES2442615T5 (es) * 2002-07-18 2023-03-16 Merus Nv Producción recombinante de mezclas de anticuerpos
KR20050044902A (ko) * 2002-08-12 2005-05-13 다케다 야쿠힌 고교 가부시키가이샤 축합 벤젠 유도체 및 용도
WO2004042030A2 (en) 2002-11-01 2004-05-21 Leucadia Technologies, Inc. Displacement sandwich immuno-pcr
AU2004232976B2 (en) * 2003-04-18 2011-02-10 Becton, Dickinson And Company Immuno-amplification
US20090176207A1 (en) * 2004-06-23 2009-07-09 Washington University Methods for Determining Risk of Developing Regular Smoking Behavior
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
JP5037350B2 (ja) 2004-11-03 2012-09-26 アイリス モレキュラー ダイアグノスティクス， インコーポレイテッド 親和性分離のための微粒気泡
AU2005333156B2 (en) 2004-11-03 2011-05-26 Iris Molecular Diagnostics, Inc. Homogeneous analyte detection
JP4692200B2 (ja) 2005-10-06 2011-06-01 横河電機株式会社 化学処理用カートリッジおよびその使用方法
PL2252893T3 (pl) * 2008-02-21 2014-03-31 Iris Int Inc Sposób wczesnego określenia nawrotu po leczeniu nowotworu gruczołu krokowego

Also Published As

Publication number Publication date
EP1842226B2 (de) 2014-07-02
EP1842226A2 (de) 2007-10-10
US9234890B2 (en) 2016-01-12
JP2012120534A (ja) 2012-06-28
CN101137758B (zh) 2012-10-10
WO2006137932A9 (en) 2007-02-15
US8338579B2 (en) 2012-12-25
CA2585781A1 (en) 2006-12-28
ES2352041T3 (es) 2011-02-15
AU2005333156B2 (en) 2011-05-26
EP1842226A4 (de) 2009-08-05
CN103146808A (zh) 2013-06-12
EP1842226B1 (de) 2010-09-08
DK1842226T3 (da) 2010-10-18
JP2008518605A (ja) 2008-06-05
WO2006137932A3 (en) 2007-09-20
KR20070105967A (ko) 2007-10-31
JP5188808B2 (ja) 2013-04-24
PT1842226E (pt) 2010-11-29
US20120082988A1 (en) 2012-04-05
DE602005023529D1 (de) 2010-10-21
US20080131883A1 (en) 2008-06-05
CN101137758A (zh) 2008-03-05
WO2006137932A2 (en) 2006-12-28
ES2352041T5 (es) 2014-12-22
AU2005333156A1 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
ATE480643T1 (de) Homogener nachweis von analyten
ATE330038T1 (de) Nukleinsäure-biosensor
CY1124802T1 (el) Δεσμευτικοι παραγοντες σκληροστινης
DE60322339D1 (de) Bindungsproteine als biosensoren
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
ATE514755T1 (de) Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung
NO20076003L (no) TGF-beta 1 spesifikke antistoffer
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
NO20043245L (no) Bindingsproteiner som biosensorer
ATE419388T1 (de) Nukleinsäureanreicherung
ATE513833T1 (de) Thienopyridinverbindungen und verfahren zu ihrer verwendung
DK1721992T3 (da) Fremgangsmåder og nukleinsyrer til analyser af cellulære proliferative sygdomme
DE602004010151D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
DK1381697T3 (da) Cirkulær probe-amplifikation (CPA) af ringformede nukleinsyremolekyler
NO20070757L (no) Ny sekvens for forbedring av ekspresjon av nukleinsyre(r)
ATE466080T1 (de) Formulierungen und verfahren zum denaturieren von proteinen
EA200300880A1 (ru) Способ детекции нуклеотидного полиморфизма
DE602005001302D1 (de) Bestimmung von analytcharakteristika auf der grundlage von bindungseigenschaften
ATE428417T1 (de) Derivate von piperidinylalkylcarbamaten, herstellungsverfahren davon und verwendung derselben als faah-enzym-inhibitoren
ATE466283T1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
ATE414701T1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
ATE495243T1 (de) Verfahren zur herstellung von hochempfindlichen endonukleasen, neuartige zubereitungen von nukleasen und ihre verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1842226

Country of ref document: EP